Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Blog In Health

FDA issue list of products with safety label changes

By Tim Sandle
Posted Apr 13, 2012 in Health
The US Food and Drug Administration (FDA) has issued a list of medicines which have received safety lable changes over the past four weeks.
Further details can be found at [url=http://: t=_blank]FDA Medwatch.
Here is the list:
Atacand HCT (candesartan cilextetil/hydrochlorothiazide)
Benicar (olmesartan medoxomil)
Sporanox (itraconazole)
Twynsta (telmisartan/amlodipine)
Zestoretic (lisinopril/hydrochlorothiazide)
Zestril (lisinopril)
Benlysta (belimumab)
Celexa (citalopram hydrobromide)
Enablex (darifenacin)
Incivek (telaprevir)
Janumet (sitagliptin and metformin fixed-dose combination)
Januvia (sitagliptin)
Kombiglyze XR (saxagliptin/metformin hydrochloride extended-release)
Lidocaine in 5% Dextrose Injection
Magnevist (brand of gadopentetate dimeglumine)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Treximet (sumatriptan and naproxen sodium)
Votrient (pazopanib)
Zometa (zoledronic acid)
Zmax (azithromycin extended release)

More about Fda, Medicine